Journal of Substance Abuse Treatment
Volume 37, Issue 4 , Pages 431-434 , December 2009

Effects of research setting on observed depressive symptoms in marijuana users

Received 28 April 2009 ,Accepted 12 May 2009.

References 

  1. Agosti V, Levin FR. Predictors of treatment contact among individuals with cannabis dependence. American Journal of Drug and Alcohol Abuse. 2004;30:121–127
  2. Arendt M, Munk-Jorgensen P. Heavy cannabis users seeking treatment—Prevalence of psychiatric disorders. Social Psychiatry and Psychiatric Epidemiology. 2004;39:97–105
  3. Arendt M, Rosenberg R, Fjordback L, Brandholdt J, Foldager L, Sher L, et al. Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychological Medicine. 2007;37:935–945
  4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 1961;4:561–571
  5. Budney AJ, Higgins ST, Radonovich KJ, Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. Journal of Consulting and Clinical Psychology. 2000;68:1051–1061
  6. Chen CY, Wagner FA, Anthony JC. Marijuana use and the risk of major depressive episode. Epidemiological evidence from the United States National Comorbidity Survey. Social Psychiatry and Psychiatric Epidemiology. 2002;37:199–206
  7. Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA. 2004;291:2114–2121
  8. Copeland J, Swift W, Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment. 2001;20:45–52
  9. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003;98:1493–1504
  10. Grant BF, Pickering R. The relationship between cannabis use and DSM-IV cannabis abuse and dependence: Results from the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse. 1998;10:255–264
  11. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry. 2004;61:807–816
  12. Kalant H. Adverse effects of cannabis on health: An update of the literature since 1996. Progress in Neuro-psychopharmacology & Biological Psychiatry. 2004;28:849–863
  13. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51:8–19
  14. Rabbitt P, Donlan C, Watson P, McInnes L, Bent N. Unique and interactive effects of depression, age, socioeconomic advantage, and gender on cognitive performance of normal healthy older people. Psychology and Aging. 1995;10:307–313
  15. Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of depression by race/ethnicity: Findings from the National Health and Nutrition Examination Survey III. American Journal of Public Health. 2005;95:998–1000
  16. The Marijuana Treatment Project Research Group. Brief treatments for cannabis dependence: Findings from a randomized multisite trial. Journal of Consulting and Clinical Psychology. 2004;72:455–466

PII: S0740-5472(09)00087-7

doi: 10.1016/j.jsat.2009.05.002

Journal of Substance Abuse Treatment
Volume 37, Issue 4 , Pages 431-434 , December 2009

Article Tools

* Image Usage & Resolution